Men in Japan with hemophilia and HIV had a 23 times higher risk of liver cancer and a 9.4 times rise in thyroid cancer ...

With bleeding disorders, surgical procedures must be carefully considered, says columnist. Saying no is an option.

Intensive factor VIII replacement therapy led to improved joint health and resolution of synovial hypertrophy in hemophilia A ...

Columnist Alliah Czarielle shares her recipe for happiness during the holiday hustle in a family with chronic health conditions.

Columnist G Shellye Horowitz's health issues pose challenges during her tap class, but she's resolved to find ways to keep on ...

Adults and adolescents with hemophilia A or hemophilia B without inhibitors experienced significantly fewer bleeding episodes when using concizumab as a prophylactic (preventive) treatment compared ...

Columnist Joe MacDonald recalls how he ended up including extended family in his immediate family's Thanksgiving celebration in the hospital.

Metagenomi is preparing to initiate IND-enabling activities that seek to support MGX-001’s transition from preclinical to ...

Rev. Cazandra Campos-MacDonald is a pastor, author, motivational speaker, and encourager. She lives in New Mexico with her husband, Rev. Dr. Joe MacDonald, and youngest son, Caeleb. Their adult son, ...

Adults and adolescents with hemophilia A or hemophilia B without inhibitors experienced significantly fewer bleeding episodes when using concizumab as a prophylactic (preventive) treatment compared ...

Real-world use of the extended half-life factor replacement therapy Elocta (efmoroctocog alfa) was associated with better bleed control than standard half-life products among people with hemophilia A, ...